Nanterinone

This classification denotes a phosphodiesterase inhibitor with the molecular formula C15H15N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1S169L7KAV, chemically known as 6-(2,4-dimethylimidazol-1-yl)-8-methyl-2-quinolone but generally known as nanterinone, which bears US NIH Compound Identifier 71305. European Medicines Agency schedules Nanterinone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09150MIG. The term NANTERINONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). NANTERINONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nanterinone under HS 29337900 and SITC 51561. As of Q4 2014, NANTERINONE remains the US FDA Preferred Term for this commodity. Nanterinone bears US NLM identifiers UMLS ID C0526440 and NCI Concept Code C76889. SMILES: O=c1[nH]c2c(cc(n3c(nc(c3)C)C)cc2C)cc1.